Marek Mysliveček

机构：Charles University, B. Braun (Czechia), General University Hospital in Prague

发表论文 13 篇 · 总被引 138 次 · h-index 4

代表论文

• Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study (2022 · Journal of the American Society of Nephrology · 被引 66)
• Risk Stratification to Predict Renal Survival in Anti–Glomerular Basement Membrane Disease (2022 · Journal of the American Society of Nephrology · 被引 36)
• Chronic kidney disease and pregnancy outcomes (2021 · Scientific Reports · 被引 23)
• Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury (2020 · Journal of Nephrology · 被引 7)
• The frequency of, and predisposing risk factors for, ciprofloxacin-induced neuro-psychiatric adverse drug reactions (2023 · Bratislavské lekárske listy/Bratislava medical journal · 被引 4)
• #4803 ANCA RENAL RISK SCORE 2023: THE UPDATED AND REVISED ARRS (2023 · Nephrology Dialysis Transplantation · 被引 2)